Abstract:Abstract Purpose This study aimed to profile the characteristics of patients with colorectal cancer (CRC) with a second primary malignancy (SPM) and to identify patients with CRC at high risk of developing SPMs. Methods We retrospectively reviewed data on patients with CRC aged 20–79 years from the Surveillance, Epidemiology, and End Results (SEER) database. Eligible patients were categorized into only one primary malignancy and SPM cohorts. A competing‐risk model was used to quantify associations between SPM occurrence and the multiple traits of patients. Finally, a decision curve analysis (DCA) was used to evaluate the clinical usefulness of the model by calculating net benefit. Results A total of 179,884 patients were identified, 18,285 (10.2%) of whom developed SPMs during a maximum follow‐up of approximately 18 years. The median survival time after the second diagnosis was less than 4 years. The 3‐year, 5‐year, and 10‐year cumulative risks of developing an SPM were 3.9%, 5.9%, and 10.0%, respectively. According to the multivariable competing‐risk model, male colon cancer survivors, older in age, with a well‐differentiated tumor and localized disease, who were treated with surgery were susceptible to SPMs. The DCA yielded a wide range of risk thresholds at which the net benefits would be obtained from our proposed model. Conclusion CRC survivors remain at high risk of developing SPMs. Patients with a second diagnosis of cancer showed not only significantly worse survival but also higher cancer‐specific mortality. A web‐based individualized predictive tool was also provided to assist clinicians in identifying patients at high risk of developing SPMs and planning their future care management. Implications for Practice Colorectal cancer survivors remain at high risk of developing a second primary malignancy (SPM). This study aimed to profile the characteristics of patients with colorectal cancer with second primary malignancies and to further explore the risk factors related to the development of second primary malignancies, using a large population‐based cohort. A clinically useful competing‐risk nomogram was developed to predict the risk of SPMs based on individual clinical factors. According to the findings, older age, male sex, white or black race, localized disease, and treatment with surgery among patients with colon cancer were associated with an increased risk of developing an SPM. These findings and the proposed tool could be useful to clinicians and caregivers in the clinical counseling of patients with colorectal cancer and the development of long‐term care management.

Risk Prediction of Second Primary Malignancies in Primary Early-Stage Ovarian Cancer Survivors: A SEER-Based National Population-Based Cohort Study

Risk of Second Primary Cancers among Long-Term Survivors of Breast Cancer

Risk of Second Primary Malignancy after Non-Small Cell Lung Cancer: a Competing Risk Nomogram Based on the SEER Database

Second Primary Malignancies after Ovarian Cancer: A SEER-based Analysis (1975–2016)

Survival Analysis of Second Primary Malignancies after Cervical Cancer Using a Competing Risk Model: Implications for Prevention and Surveillance.

Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis

A Competing-Risk Nomogram Predicting Second Primary Malignancy in Hepatocellular Carcinoma Survivors

Nomograms constructed for predicting diagnosis and prognosis in cervical cancer patients with second primary malignancies: a SEER database analysis

Second Primary Malignancies in Patients With Hepatocellular Carcinoma: A Population-Based Analysis

The Incidence of Second Primary Cancer in Male and Female Patients with Initial Colorectal Cancer: a SEER Population-Based Study.

Risk Factors and Prediction of Second Primary Cancer in Primary Female Non-Metastatic Breast Cancer Survivors

The Effects of a Prior Malignancy on the Survival of Patients with Ovarian Cancer: a Population-Based Study

Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancer

Risk-based screening for second primary extrapulmonary malignancies in stage I lung cancer patients: a study based on SEER database

A nomogram for overall survival of second primary cancers following upper-tract urothelial carcinoma: a SEER population-based study

Risk of Second Primary Malignancies in Colon Cancer Patients Treated With Colectomy

Analyzing risk factors for second malignancies in early gastric carcinoma from the SEER database

Development and validation of nomograms to predict the survival probability and occurrence of a second primary malignancy of male breast cancer patients: a population-based analysis

Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study

Survival Prediction in Second Primary Breast Cancer Patients with Machine Learning: An Analysis of SEER Database

Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous carcinoma: Insights from the SEER database